Skip to main content

Advertisement

Table 1 General and clinical data of HCC patients and controls groups

From: MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case–control study

  HCC patients (%) n = 119 Controls (%) n = 103
Age (Mean ± SD) 63.45 ± 12.59 56 ± 10.82
Sex ratio (M:F) 1.53 (72/47) 1.29 (58/45)
Ongoing co-infection HBV + HCV 4 (3.4) 0
Chronic hepatitis B (HBsAg+) 12 (10.1) 0
Chronic hepatitis C (anti-HCV+) 76 (63.9) 0
Resolved Hepatitis B (HBsAg-/anti-HBc+) 40 (33.6) 30 (29.1)
No history of hepatitis B or C 15 (12.6) 73 (70.9)
Type 2 Diabetes 7 (5.9) 1 (0.9)